Background Human skin is able to mount a fast response against invading microorganisms by the release of antimicrobial proteins such as the ribonuclease RNase 7. Because RNase 7 exhibits high activity against Enterococcus faecium the aim of this study was to further explore the role of RNase 7 in the cutaneous innate defense system against E. faecium. Methodology/Principal Findings Absolute quantification using real-time PCR and ELISA revealed that primary keratinocytes expressed high levels of RNase 7. Immunohistochemistry showed RNase 7 expression in all epidermal layers of the skin with an intensification in the upper more differentiated layers. Furthermore, RNase 7 was secreted by keratinocytes in vitro and in vivo in a site-dependent way. RNase 7 was still active against E. faecium at low pH (5.5) or high NaCl (150 mM) concentration and the bactericidal activity of RNase 7 against E. faecium required no ribonuclease activity as shown by recombinant RNase 7 lacking enzymatic activity. To further explore the role of RNase 7 in cutaneous defense against E. faecium, we investigated whether RNase 7 contributes to the E. faecium killing activity of skin extracts derived from stratum corneum. Treatment of the skin extract with an RNase 7 specific antibody, which neutralizes the antimicrobial activity of RNase 7, diminished its E. faecium killing activity. Conclusions/Significance Our data indicate that RNase 7 contributes to the E. faecium-killing activity of skin extracts and suggest an important role for RNase 7 in the protection of human skin against E. faecium colonization.
References
[1]
Braff MH, Bardan A, Nizet V, Gallo RL (2005) Cutaneous defense mechanisms by antimicrobial peptides. J Invest Dermatol 125: 9–13.
[2]
Harder J, Schr？der JM (2005) Antimicrobial peptides in human skin. Chem Immunol Allergy 86: 22–41.
[3]
Schr？der JM, Harder J (2006) Antimicrobial skin peptides and proteins. Cell Mol Life Sci 63: 469–486.
[4]
Chromek M, Slamova Z, Bergman P, Kovacs L, Podracka L, et al. (2006) The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 12: 636–641.
[5]
Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, et al. (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414: 454–457.
[6]
Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL (2003) Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422: 522–526.
[7]
De Smet K, Contreras R (2005) Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol Lett 27: 1337–1347.
[8]
Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415: 389–395.
[9]
Zanetti M (2004) Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 75: 39–48.
[10]
Zanetti M (2005) The role of cathelicidins in the innate host defenses of mammals. Curr Issues Mol Biol 7: 179–196.
[11]
Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, et al. (2004) IL-22 increases the innate immunity of tissues. Immunity 21: 241–254.
[12]
Wehkamp K, Schwichtenberg L, Schr？der JM, Harder J (2006) Pseudomonas aeruginosa- and IL-1beta-mediated induction of human beta-defensin-2 in keratinocytes is controlled by NF-kappaB and AP-1. J Invest Dermatol 126: 121–127.
[13]
Sorensen OE, Thapa DR, Rosenthal A, Liu L, Roberts AA, et al. (2005) Differential Regulation of {beta}-Defensin Expression in Human Skin by Microbial Stimuli. J Immunol 174: 4870–4879.
[14]
Schr？der JM, Harder J (1999) Human beta-defensin-2. Int J Biochem Cell Biol 31: 645–651.
[15]
Dorschner RA, Pestonjamasp VK, Tamakuwala S, Ohtake T, Rudisill J, et al. (2001) Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 117: 91–97.
[16]
Conner K, Nern K, Rudisill J, O'Grady T, Gallo RL (2002) The antimicrobial peptide LL-37 is expressed by keratinocytes in condyloma acuminatum and verruca vulgaris. J Am Acad Dermatol 47: 347–350.
[17]
Harder J, Schr？der JM (2005) Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins. J Leukoc Biol 77: 476–486.
[18]
Gl？ser R, Harder J, Lange H, Bartels J, Christophers E, et al. (2005) Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 6: 57–64.
[19]
Dyer KD, Rosenberg HF (2006) The RNase a superfamily: generation of diversity and innate host defense. Mol Divers 10: 585–597.
[20]
Domachowske JB, Dyer KD, Adams AG, Leto TL, Rosenberg HF (1998) Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity. Nucleic Acids Res 26: 3358–3363.
[21]
Domachowske JB, Dyer KD, Bonville CA, Rosenberg HF (1998) Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. J Infect Dis 177: 1458–1464.
[22]
Lehrer RI, Szklarek D, Barton A, Ganz T, Hamann KJ, et al. (1989) Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J Immunol 142: 4428–4434.
[23]
Hooper LV, Stappenbeck TS, Hong CV, Gordon JI (2003) Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 4: 269–273.
[24]
Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, et al. (1985) Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 24: 5480–5486.
[25]
Harder J, Schr？der JM (2002) RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem 277: 46779–46784.
[26]
Zhang J, Dyer KD, Rosenberg HF (2003) Human RNase 7: a new cationic ribonuclease of the RNase A superfamily. Nucleic Acids Res 31: 602–607.
[27]
Gl？ser R, Navid F, Schuller W, Jantschitsch C, Harder J, et al. (2009) UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo. J Allergy Clin Immunol 123: 1117–1123.
[28]
Gambichler T, Skrygan M, Tomi NS, Othlinghaus N, Brockmeyer NH, et al. (2008) Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin. Int Arch Allergy Immunol 147: 17–24.
[29]
Rudolph B, Podschun R, Sahly H, Schubert S, Schr？der JM, et al. (2006) Identification of RNase 8 as a novel human antimicrobial protein. Antimicrob Agents Chemother 50: 3194–3196.
[30]
Rosenberg HF, Domachowske JB (2001) Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. J Leukoc Biol 70: 691–698.
[31]
Rosenberg HF, Domachowske JB (1999) Eosinophils, ribonucleases and host defense: solving the puzzle. Immunol Res 20: 261–274.
[32]
Reithmayer K, Meyer KC, Kleditzsch P, Tiede S, Uppalapati SK, et al. (2009) Human hair follicle epithelium has an antimicrobial defence system that includes the inducible antimicrobial peptide psoriasin (S100A7) and RNase 7. Br J Dermatol.
[33]
Rosenberg HF (1995) Recombinant human eosinophil cationic protein. Ribonuclease activity is not essential for cytotoxicity. J Biol Chem 270: 7876–7881.
[34]
Huang YC, Lin YM, Chang TW, Wu SJ, Lee YS, et al. (2007) The flexible and clustered lysine residues of human ribonuclease 7 are critical for membrane permeability and antimicrobial activity. J Biol Chem 282: 4626–4633.
[35]
Nitto T, Dyer KD, Czapiga M, Rosenberg HF (2006) Evolution and function of leukocyte RNase A ribonucleases of the avian species, Gallus gallus. J Biol Chem 281: 25622–25634.
[36]
Abtin A, Eckhart L, Mildner M, Ghannadan M, Harder J, et al. (2009) Degradation by Stratum Corneum Proteases Prevents Endogenous RNase Inhibitor from Blocking Antimicrobial Activities of RNase 5 and RNase 7. J Invest Dermatol.
[37]
Johnson RJ, McCoy JG, Bingman CA, Phillips GN Jr, Raines RT (2007) Inhibition of human pancreatic ribonuclease by the human ribonuclease inhibitor protein. J Mol Biol 368: 434–449.
[38]
Pazgier M, Hoover DM, Yang D, Lu W, Lubkowski J (2006) Human beta-defensins. Cell Mol Life Sci 63: 1294–1313.
[39]
Selsted ME, Ouellette AJ (2005) Mammalian defensins in the antimicrobial immune response. Nat Immunol 6: 551–557.
[40]
Powers JP, Hancock RE (2003) The relationship between peptide structure and antibacterial activity. Peptides 24: 1681–1691.
[41]
Wiedow O, Harder J, Bartels J, Streit V, Christophers E (1998) Antileukoprotease in human skin: an antibiotic peptide constitutively produced by keratinocytes. Biochem Biophys Res Commun 248: 904–909.
[42]
Harder J, Bartels J, Christophers E, Schr？der JM (2001) Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276: 5707–5713.
[43]
Voss E, Wehkamp J, Wehkamp K, Stange EF, Schr？der JM, et al. (2006) NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J Biol Chem 281: 2005–2011.
[44]
Schr？der JM, Gregory H, Young J, Christophers E (1992) Neutrophil-activating proteins in psoriasis. J Invest Dermatol 98: 241–247.
